6-Chloro-N-[(2-ethyl-1-methyl-1H-imidazol-5-yl)methyl]-N-methyl-2-[6-methyl-5-[[2-(methylamino)ethyl]amino]-2-pyridinyl]-4-quinolinecarboxamide

Request For Quotation
6-Chloro-N-[(2-ethyl-1-methyl-1H-imidazol-5-yl)methyl]-N-methyl-2-[6-methyl-5-[[2-(methylamino)ethyl]amino]-2-pyridinyl]-4-quinolinecarboxamide Basic information
Product Name:6-Chloro-N-[(2-ethyl-1-methyl-1H-imidazol-5-yl)methyl]-N-methyl-2-[6-methyl-5-[[2-(methylamino)ethyl]amino]-2-pyridinyl]-4-quinolinecarboxamide
Synonyms:6-Chloro-N-[(2-ethyl-1-methyl-1H-imidazol-5-yl)methyl]-N-methyl-2-[6-methyl-5-[[2-(methylamino)ethyl]amino]-2-pyridinyl]-4-quinolinecarboxamide;Anticancer agent 112
CAS:2495321-37-2
MF:C27H32ClN7O
MW:506.04
EINECS:
Product Categories:
Mol File:2495321-37-2.mol
6-Chloro-N-[(2-ethyl-1-methyl-1H-imidazol-5-yl)methyl]-N-methyl-2-[6-methyl-5-[[2-(methylamino)ethyl]amino]-2-pyridinyl]-4-quinolinecarboxamide Structure
6-Chloro-N-[(2-ethyl-1-methyl-1H-imidazol-5-yl)methyl]-N-methyl-2-[6-methyl-5-[[2-(methylamino)ethyl]amino]-2-pyridinyl]-4-quinolinecarboxamide Chemical Properties
Boiling point 761.4±60.0 °C(Predicted)
density 1.26±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)
pka9.80±0.10(Predicted)
Safety Information
MSDS Information
6-Chloro-N-[(2-ethyl-1-methyl-1H-imidazol-5-yl)methyl]-N-methyl-2-[6-methyl-5-[[2-(methylamino)ethyl]amino]-2-pyridinyl]-4-quinolinecarboxamide Usage And Synthesis
UsesAnticancer agent 112 is a potent anti-cancer agent for cancer research, extracted from patent WO2020198567[1].
References[1] Eamon Comer, et al. Quinoline derivatives and their use for the treatment of cancer. Patent WO2020198567
6-Chloro-N-[(2-ethyl-1-methyl-1H-imidazol-5-yl)methyl]-N-methyl-2-[6-methyl-5-[[2-(methylamino)ethyl]amino]-2-pyridinyl]-4-quinolinecarboxamide Preparation Products And Raw materials
Tag:6-Chloro-N-[(2-ethyl-1-methyl-1H-imidazol-5-yl)methyl]-N-methyl-2-[6-methyl-5-[[2-(methylamino)ethyl]amino]-2-pyridinyl]-4-quinolinecarboxamide(2495321-37-2) Related Product Information
Human IgG1, kappa Isotype Control FORSYTHOSIDE A Zolbetuximab beta-D-Fructopyranose Tectorigenin Anti-Mouse Ly6G Antibody (1A8)